Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells

ConclusionOur study identifies the combination of entinostat with olaparib as a new potential therapeutic approach forMYC-driven Group 3  MB.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research